Agenda http://www.imim.cat/agenda/ Programa de recerca: Càncer IkBa controls dormancy induction in Hematopoietic stem cell development via retinoic acid http://www.imim.cat/noticies/view.php?ID=730 <p>Us convidem al pròxim IMIM Seminar organitzat pel Programa de Cancer, que tindrà lloc el dimecres 25/05/2022 a les 14:00 h. El títol serà <strong>&quot;I&kappa;B&alpha; controls dormancy induction in&nbsp;Hematopoietic stem cell development via retinoic acid&quot;</strong>, a càrrec de la <strong>Dra.Roshana Thambyrajah</strong>,investigadora postdoctoral del&nbsp;Grup de recerca en cèl&middot;lules mare i càncer (IMIM).</p> 25/05/2022 Sala Xipre a les 14:00h Optimizing Immunotherapy: New Approaches, Biomarkers, Sequences and Combinations http://www.imim.cat/noticies/view.php?ID=716 <p>On June 17 will take place&nbsp;a new edition of the Congress&nbsp;&quot;<strong>Optimizing Immunotherapy. New Approaches, Biomarkers, Sequences and Combinations&quot;</strong>, organized by Dr. Joaquim Bellmunt and Dr. Edurne Arriola. This edition will be also in hybrid format.</p> <p>In case you need more information please click <a href="https://optimizingimmunotherapy.com/">https://optimizingimmunotherapy.com/</a></p> 17/06/2022 http://www.imim.cat/media/upload/gif/220407b-imim-oi-2022-programa-1p_editora_5_716_1.png Hybrid Congress (8:30h - 16:00 h)